While Lithuania, Latvia and Estonia have a lot in common – small, high-income economies and Eurozone members situated on the Eastern coast of the Baltic Sea – it would be inadvisable to consider the Baltic states as one homogenous block.
This report explores the peculiarities of the healthcare and life science industries of these petite but promising markets, as well as the ways in which actors from across the Baltics are working together on issues such as regulatory harmonization for medicine approvals and innovation clustering to propel the region’s industry forwards.
